Subscribe to RSS
DOI: 10.1055/a-1642-1234
Gewinnung von Stammzellen aus Nabelschnurblut: Relevanz peripartaler Faktoren für die Qualität von Transplantaten
Harvest of Stem Cells from Umbilical Cord Blood: Relevance of Perinatal Factors for the Quality of Umbilical Cord Transplant Units
Zusammenfassung
Einleitung Nabelschnurblut (NSB) enthält hämatopoetische Stammzellen mit therapeutischem Potenzial und einzigartigen zellulären Eigenschaften. Aufgrund der begrenzten Anzahl an Stammzellen im NSB (Surrogatmarker total nucleated cells, TNC) eignet sich nur jede fünfte Spende für eine Transplantation. Ziel dieser Studie war es, zu untersuchen, ob prädiktive Faktoren für eine TNC-Zahl über der 99. Perzentile existieren.
Material und Methodik Retrospektive Datenanalyse der 100 größten NSB-Spenden (Top100-Kohorte) aus 2299 registrierten Einheiten. Unterschiede zwischen maternalen, fetalen und geburtshilflichen Faktoren wurden analysiert und mit einer standardisierten Kohorte von 731 NSB-Spenden verglichen.
Ergebnisse Das mütterliche Alter und der BMI in der Top100-Kohorte waren höher als in der Vergleichskohorte (32 vs. 31 Jahre, p=0,007; 30 kg/m2 vs. 29 kg/m2, p=0,024). Es gab mehr Erstgebärende (76,0 vs. 62,8%, p=0,013) und Gestationsdiabetikerinnen (5,00 vs. 1,65%, p=0,044). Die Schwangerschaftswoche, das Geburtsgewicht, der Anteil vaginal-operativer Geburten und sekundärer Sectiones war in der Top100-Kohorte höher (40+4 vs. 40+1 SSW, p=0,002), (3700 vs. 3450 g, p<0,001), (53,0 vs. 22,7%, p<0,001) (10 vs. 6,2%, p=0,014).
Fazit Für eine erfolgreiche Transplantation ist die Höhe der TNC-Zahl entscheidend. Vaginal-operative Entbindungen, sekundäre Sectiones und ein Geburtsgewicht über 3700 g sind günstige Faktoren. Gerade bei Geburten mit einem pathologischen Verlauf sollte nach sicherer Versorgung von Mutter und Kind nicht auf eine Entnahme verzichtet werden.
Abstract
Introduction Umbilical cord blood (UCB) contains hematopoietic stem cells with therapeutic potential and unique cellular properties. Due to the limited number of stem cells in the UCB (surrogate marker total nucleated cells, TNC), only one in five donations is suitable for transplantation. The aim of this study was to investigate whether predictive factors exist for a TNC count above the 99th percentile.
Material and methods Retrospective data analysis of the 100 largest donations from 2,299 registered UCB units. Differences between maternal, fetal, and obstetric factors were analyzed and compared with a standardized cohort of 731 registered UCB units.
Results maternal age and BMI in the Top100 cohort were higher compared with the comparative cohort (32 vs. 31 years, p=0.007; 30 kg/m2 vs. 29 kg/m2, p=0.024). There were significantly more P1 (76.0 vs. 62.8%, p=0.013) and women with gestational diabetes (5.00 vs. 1.65%, p=0.044). The gestational week, birth weight, the proportion of vaginal-operative deliveries and secondary caesarean sections were higher in the Top100 cohort (40+4 vs. 40+1 wks, p=0.002), (3700 vs. 3450 g, p<0.001), (53.0 vs. 22.7%, p<0.001) (10 vs. 6.2%, p=0.014).
Conclusion For a successful transplant, the amount of TNC in the UCB unit is crucial. Vaginal-operative deliveries, secondary caesarean sections, and a birth weight above 3700 g are favorable with regard to stem cell content. In cases with a complicated course of delivery, collection should not be neglected once the mother and child are safely cared for.
Schlüsselwörter
Nabelschnurblut - Öffentliche Nabelschnurblutspende - Stammzelltransplantation - Private NabelschnurblutspendeKey words
umbilical cord blood - public umbilical cord blood banking - stem cell transplantation - private umbilical cord blood bankingPublication History
Received: 22 April 2021
Accepted after revision: 26 August 2021
Article published online:
27 September 2021
© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Broxmeyer HE, Douglas GW, Hangoc G. et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989; 86: 3828-3832 DOI: 10.1073/pnas.86.10.3828.
- 2 Snowden JA, Saccardi R, Allez M. et al. Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2012; 47: 770-790 DOI: 10.1038/bmt.2011.185.
- 3 Passweg JR, Baldomero H, Bader P. et al. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Bone Marrow Transplant 2016; 51: 786-792 DOI: 10.1038/bmt.2016.20.
- 4 Passweg JR, Baldomero H, Bader P. et al. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplant 2017; 52: 811-817 DOI: 10.1038/bmt.2017.34.
- 5 Michael Boo JD, President W. 2015–2016. WMDA Activities Report 2016 World Marrow Donor Association. 2016
- 6 Gluckman E. Milestones in umbilical cord blood transplantation. Blood Rev 2011; 25: 255-259 DOI: 10.1016/j.blre.2011.06.003.
- 7 Laughlin MJ, Eapen M, Rubinstein P. et al. Outcomes after Transplantation of cord blood or bone barrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 25: 351 2265-2275 DOI: 10.1056/NEJMoa041276.
- 8 Mazzocchetti D, Berti AM, Sartini R. et al. Total nucleated cells as a sole predictor of distinct targets of hematopoietic potential (CD34+cells) in cord blood units: The results of a large series analysis in autologous cord blood units. Transfusion 2014; 54: 1256-1262 DOI: 10.1111/trf.12458.
- 9 Manegold-Brauer G, Borner B, Bucher C. et al. A prenatal prediction model for total nucleated cell count increases the efficacy of umbilical cord blood banking. Transfusion 2014; 54: 2946-2952 DOI: 10.1111/trf.12676.
- 10 Page KM, Mendizabal A, Betz-Stablein B. et al. Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality. Transfusion 2014; 54: 340-352 DOI: 10.1111/trf.12257.
- 11 Hothorn T, Hornik K, Zeileis A. Unbiased Recursive Partitioning: A Conditional Inference Framework. J Comput Graph Stat 2006; 651-674 DOI: 10.1198/106186006X133933.
- 12 Barker JN, Scaradavou A, Stevens CE. Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. Blood 2010; 115: 1843-1849 DOI: 10.1182/blood-2009-07-231068.
- 13 Barker JN, Byam C, Scaradavou A. How I treat: the selection and acquisition of unrelated cord blood grafts. Blood 2011; 117: 2332-2339 DOI: 10.1182/blood-2010-04-280966.
- 14 Hough R, Danby R, Russell N. et al. Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocols. Br J Haematol 2016; 172: 360-370 DOI: 10.1111/bjh.13802.
- 15 Manegold G, Meyer-Monard S, Tichelli A. et al. Cesarean section due to fetal distress increases the number of stem cells in umbilical cord blood. Transfusion 2008; 48: 871-876 DOI: 10.1111/j.1537-2995.2007.01617.x.
- 16 Wu S, Xie G, Wu J. et al. Influence of maternal, infant, and collection characteristics on high-quality cord blood units in Guangzhou Cord Blood Bank. Transfusion 2015; 55: 2158-2167 DOI: 10.1111/trf.13126.
- 17 Aroviita P, Teramo K, Hiilesmaa V. et al. Cord blood hematopoietic progenitor cell concentration and infant sex. Transfusion 2005; 45: 613-621 DOI: 10.1111/j.0041-1132.2005.04268.x.
- 18 Page KM, Zhang L, Mendizabal A. et al. The Cord Blood Apgar: a novel scoring system to optimize selection of banked cord blood grafts for transplantation (CME). Transfusion 2012; 52: 272-283 DOI: 10.1111/j.1537-2995.2011.03278.x.
- 19 Faivre L, Couzin C, Boucher H. et al. Associated factors of umbilical cord blood collection quality. Transfusion 2018; 58: 520-531 DOI: 10.1111/trf.14447.
- 20 Ballen KK, Wilson M, Wuu J. et al. Bigger is better: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units. Bone Marrow Transplant 2001; 27: 7-14 DOI: 10.1038/sj.bmt.1702729.
- 21 Omori A, Hirai M, Chiba T. et al. Quality-assessments of characteristics of placental/umbilical cord blood associated with maternal age- and parity-related factor. Transfus Apher Sci 2012; 46: 7-13 DOI: 10.1016/j.transci.2011.10.030.
- 22 Valéria Santos S, Marti L, Ribeiro AAF. et al. A cross-sectional study of umbilical cord blood donor profiles and their influence on umbilical cord blood collection in a Brazilian hospital. Cytotherapy 2011; 13: 1120-1127 DOI: 10.3109/14653249.2011.598145.